Moreover, in an analysis of 45 pancreatic cancer patients treated with postoperative adjuvant gemcitabine-based chemoradiation therapy, patients with high hENT1 expression had significantly longer DFS and OS than those with low hENT1 expression, and hENT1 expression was the only independent predictor for DFS and OS (Maréchal et al., 2009). This evidence concerns the gene SLC29A1 and pancreatic neoplasm.